Valuation: Supergenics

Market Cap 2.91Cr 71.5L 62.54L 57.68L 53.28L 1.01Cr 68Cr 1.03Cr 6.89Cr 2.71Cr 34Cr 2.68Cr 2.63Cr 115.48Cr P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 3.25Cr 79.83L 69.83L 64.41L 59.49L 1.13Cr 76Cr 1.15Cr 7.7Cr 3.02Cr 38Cr 3Cr 2.93Cr 128.95Cr EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 24/04/2019
Corporate Secretary - 02/06/2022
Director TitleAgeSince
Director/Board Member 48 24/04/2019
Director/Board Member 60 24/04/2019
Director/Board Member 46 28/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%+13.64% 71.5L
+0.58%+2.06%+2.92%+10.86% 5.07TCr
-2.22%-1.25%+385.40%+586.81% 3.97TCr
-0.54%+0.39%+25.57%-5.28% 3.47TCr
-1.36%+0.35%+17.88%+55.14% 3.32TCr
+1.21%-4.58%+3.00%+35.46% 2.68TCr
-1.81%-1.48% - - 1.68TCr
+0.51%-3.47%+63.97%+122.60% 1.54TCr
+0.23%-0.58%+13.76%+21.11% 1.38TCr
-0.62%-3.09%+10.29%-31.35% 1.28TCr
Average +1.79%-0.75%+56.24%+89.89% 2.44TCr
Weighted average by Cap. -0.48%-0.23%+80.69%+124.32%

Financials

2024 2025
Net sales 53.22L 13.07L 11.43L 10.55L 10L 18.48L 12Cr 18.79L 1.26Cr 49.48L 6.14Cr 49.08L 48.01L 21Cr 56.25L 13.82L 12.09L 11.15L 10.3L 19.54L 13Cr 19.87L 1.33Cr 52.31L 6.49Cr 51.88L 50.75L 22Cr
Net income -72.81L -17.88L -15.64L -14.43L -13.33L -25.29L -17Cr -25.71L -1.72Cr -67.7L -8.4Cr -67.15L -65.69L -29Cr -33.66L -8L -7L -7L -6L -11.69L -7.88Cr -11.89L -79.69L -31.3L -3.88Cr -31.04L -30.36L -13Cr
Net Debt 44.77L 11L 10L 9L 8L 15.55L 10Cr 15.81L 1.06Cr 41.63L 5.17Cr 41.29L 40.39L 18Cr 33.94L 8L 7L 7L 6L 11.79L 7.95Cr 11.99L 80.37L 31.56L 3.92Cr 31.3L 30.62L 13Cr
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock